Oligonucleotide synthesis is the chemical synthesis of relatively short fragments of nucleic acids with defined chemical structure (sequence). The technique is extremely useful in current laboratory practice because it provides a rapid and inexpensive access to custom-made oligonucleotides of the desired sequence.

Scope of the Report:

This report studies the Oligonucleotide Synthesis market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Oligonucleotide Synthesis market by product type and applications/end industries.

Oligonucleotides find a variety of applications in molecular biology and medicine. They are most commonly used as antisense oligonucleotides, small interfering RNA, primers for DNA sequencing and amplification, probes for detecting complementary DNA or RNA via molecular hybridization, tools for the targeted introduction of mutations and restriction sites, and for the synthesis of artificial genes.

The global Oligonucleotide Synthesis market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Oligonucleotide Synthesis.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Integrated DNA Technologies

Merck KGaA

Eurofins Genomics

Thermo Fisher Scientific

Bioautomation

Agilent Technologies

Eurogentec

GE Healthcare

LGC Biosearch Technologies

Nitto Denko Avecia

Genscript

Genedesign

TriLink Biotechnologies

Bio-Synthesis

ATDBio

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Synthesized Oligonucleotides

Reagents

Equipment

Market Segment by Applications, can be divided into

PCR

DNA

RNAi

Research

Therapeutic

Table of Contents

1 Oligonucleotide Synthesis Market Overview

1.1 Product Overview and Scope of Oligonucleotide Synthesis

1.2 Classification of Oligonucleotide Synthesis by Types

1.2.1 Global Oligonucleotide Synthesis Revenue Comparison by Types (2017-2023)

1.2.2 Global Oligonucleotide Synthesis Revenue Market Share by Types in 2017

1.2.3 Synthesized Oligonucleotides

1.2.4 Reagents

1.2.5 Equipment

1.3 Global Oligonucleotide Synthesis Market by Application

1.3.1 Global Oligonucleotide Synthesis Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 PCR

1.3.3 DNA

1.3.4 RNAi

1.3.5 Research

1.3.6 Therapeutic

1.4 Global Oligonucleotide Synthesis Market by Regions

1.4.1 Global Oligonucleotide Synthesis Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Oligonucleotide Synthesis Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Oligonucleotide Synthesis Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Oligonucleotide Synthesis Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Oligonucleotide Synthesis Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Oligonucleotide Synthesis Status and Prospect (2013-2023)

1.5 Global Market Size of Oligonucleotide Synthesis (2013-2023)

2 Manufacturers Profiles

2.1 Integrated DNA Technologies

2.1.1 Business Overview

2.1.2 Oligonucleotide Synthesis Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Integrated DNA Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.2 Merck KGaA

2.2.1 Business Overview

2.2.2 Oligonucleotide Synthesis Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Merck KGaA Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.3 Eurofins Genomics

2.3.1 Business Overview

2.3.2 Oligonucleotide Synthesis Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Eurofins Genomics Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.4 Thermo Fisher Scientific

2.4.1 Business Overview

2.4.2 Oligonucleotide Synthesis Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Thermo Fisher Scientific Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.5 Bioautomation

2.5.1 Business Overview

2.5.2 Oligonucleotide Synthesis Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Bioautomation Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.6 Agilent Technologies

2.6.1 Business Overview

2.6.2 Oligonucleotide Synthesis Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Agilent Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.7 Eurogentec

2.7.1 Business Overview

2.7.2 Oligonucleotide Synthesis Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Eurogentec Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.8 GE Healthcare

2.8.1 Business Overview

2.8.2 Oligonucleotide Synthesis Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 GE Healthcare Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.9 LGC Biosearch Technologies

2.9.1 Business Overview

2.9.2 Oligonucleotide Synthesis Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 LGC Biosearch Technologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.10 Nitto Denko Avecia

2.10.1 Business Overview

2.10.2 Oligonucleotide Synthesis Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Nitto Denko Avecia Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.11 Genscript

2.11.1 Business Overview

2.11.2 Oligonucleotide Synthesis Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Genscript Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.12 Genedesign

2.12.1 Business Overview

2.12.2 Oligonucleotide Synthesis Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Genedesign Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.13 TriLink Biotechnologies

2.13.1 Business Overview

2.13.2 Oligonucleotide Synthesis Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 TriLink Biotechnologies Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.14 Bio-Synthesis

2.14.1 Business Overview

2.14.2 Oligonucleotide Synthesis Type and Applications

2.14.2.1 Product A

2.14.2.2 Product B

2.14.3 Bio-Synthesis Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

2.15 ATDBio

2.15.1 Business Overview

2.15.2 Oligonucleotide Synthesis Type and Applications

2.15.2.1 Product A

2.15.2.2 Product B

2.15.3 ATDBio Oligonucleotide Synthesis Revenue, Gross Margin and Market Share (2016-2017)

3 Global Oligonucleotide Synthesis Market Competition, by Players

3.1 Global Oligonucleotide Synthesis Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Oligonucleotide Synthesis Players Market Share

3.2.2 Top 10 Oligonucleotide Synthesis Players Market Share

3.3 Market Competition Trend

4 Global Oligonucleotide Synthesis Market Size by Regions

4.1 Global Oligonucleotide Synthesis Revenue and Market Share by Regions

4.2 North America Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

4.3 Europe Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

4.5 South America Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

5 North America Oligonucleotide Synthesis Revenue by Countries

5.1 North America Oligonucleotide Synthesis Revenue by Countries (2013-2018)

5.2 USA Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

5.3 Canada Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

5.4 Mexico Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

6 Europe Oligonucleotide Synthesis Revenue by Countries

6.1 Europe Oligonucleotide Synthesis Revenue by Countries (2013-2018)

6.2 Germany Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

6.3 UK Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

6.4 France Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

6.5 Russia Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

6.6 Italy Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Oligonucleotide Synthesis Revenue by Countries

7.1 Asia-Pacific Oligonucleotide Synthesis Revenue by Countries (2013-2018)

7.2 China Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

7.3 Japan Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

7.4 Korea Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

7.5 India Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

8 South America Oligonucleotide Synthesis Revenue by Countries

8.1 South America Oligonucleotide Synthesis Revenue by Countries (2013-2018)

8.2 Brazil Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

8.3 Argentina Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

8.4 Colombia Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Oligonucleotide Synthesis by Countries

9.1 Middle East and Africa Oligonucleotide Synthesis Revenue by Countries (2013-2018)

9.2 Saudi Arabia Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

9.3 UAE Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

9.4 Egypt Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

9.5 Nigeria Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

9.6 South Africa Oligonucleotide Synthesis Revenue and Growth Rate (2013-2018)

10 Global Oligonucleotide Synthesis Market Segment by Type

10.1 Global Oligonucleotide Synthesis Revenue and Market Share by Type (2013-2018)

10.2 Global Oligonucleotide Synthesis Market Forecast by Type (2018-2023)

10.3 Synthesized Oligonucleotides Revenue Growth Rate (2013-2023)

10.4 Reagents Revenue Growth Rate (2013-2023)

10.5 Equipment Revenue Growth Rate (2013-2023)

11 Global Oligonucleotide Synthesis Market Segment by Application

11.1 Global Oligonucleotide Synthesis Revenue Market Share by Application (2013-2018)

11.2 Oligonucleotide Synthesis Market Forecast by Application (2018-2023)

11.3 PCR Revenue Growth (2013-2018)

11.4 DNA Revenue Growth (2013-2018)

11.5 RNAi Revenue Growth (2013-2018)

11.6 Research Revenue Growth (2013-2018)

11.7 Therapeutic Revenue Growth (2013-2018)

12 Global Oligonucleotide Synthesis Market Size Forecast (2018-2023)

12.1 Global Oligonucleotide Synthesis Market Size Forecast (2018-2023)

12.2 Global Oligonucleotide Synthesis Market Forecast by Regions (2018-2023)

12.3 North America Oligonucleotide Synthesis Revenue Market Forecast (2018-2023)

12.4 Europe Oligonucleotide Synthesis Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Oligonucleotide Synthesis Revenue Market Forecast (2018-2023)

12.6 South America Oligonucleotide Synthesis Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Oligonucleotide Synthesis Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Oligonucleotide Synthesis Picture

Table Product Specifications of Oligonucleotide Synthesis

Table Global Oligonucleotide Synthesis and Revenue (Million USD) Market S